SE8603591L - Detektering av erftlig hyperkolesterolemi - Google Patents

Detektering av erftlig hyperkolesterolemi

Info

Publication number
SE8603591L
SE8603591L SE8603591A SE8603591A SE8603591L SE 8603591 L SE8603591 L SE 8603591L SE 8603591 A SE8603591 A SE 8603591A SE 8603591 A SE8603591 A SE 8603591A SE 8603591 L SE8603591 L SE 8603591L
Authority
SE
Sweden
Prior art keywords
disclosed
hypercolesterolemia
heredic
detection
individual
Prior art date
Application number
SE8603591A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8603591D0 (sv
Inventor
M S Brown
J L Goldstein
D W Russell
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of SE8603591D0 publication Critical patent/SE8603591D0/xx
Publication of SE8603591L publication Critical patent/SE8603591L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8603591A 1984-12-28 1986-08-26 Detektering av erftlig hyperkolesterolemi SE8603591L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/687,087 US4745060A (en) 1984-12-28 1984-12-28 Methods and compositions for the detection of Familial Hypercholesterolemia
PCT/US1985/002461 WO1986004090A1 (en) 1984-12-28 1985-12-16 Methods and compositions for the detection of familial hypercholesterolemia

Publications (2)

Publication Number Publication Date
SE8603591D0 SE8603591D0 (sv) 1986-08-26
SE8603591L true SE8603591L (sv) 1986-08-26

Family

ID=24758985

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603591A SE8603591L (sv) 1984-12-28 1986-08-26 Detektering av erftlig hyperkolesterolemi

Country Status (15)

Country Link
US (2) US4745060A (fi)
EP (1) EP0205574A1 (fi)
JP (1) JPS62501327A (fi)
AU (1) AU5306586A (fi)
BR (1) BR8507148A (fi)
CH (1) CH671776A5 (fi)
DE (1) DE3590702T1 (fi)
DK (1) DK409286D0 (fi)
FI (1) FI863474A (fi)
GB (1) GB2178743B (fi)
HU (1) HUT41838A (fi)
NL (1) NL8520436A (fi)
NO (1) NO863438D0 (fi)
SE (1) SE8603591L (fi)
WO (1) WO1986004090A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683194A (en) * 1984-05-29 1987-07-28 Cetus Corporation Method for detection of polymorphic restriction sites and nucleic acid sequences
US4745060A (en) * 1984-12-28 1988-05-17 Board Of Regents, The University Of Texas System Methods and compositions for the detection of Familial Hypercholesterolemia
AU593151B2 (en) * 1986-11-12 1990-02-01 Molecular Diagnostics, Inc. Method for the detection of nucleic acid hybrids
US5256545A (en) * 1987-03-30 1993-10-26 Board Of Regents, The University Of Texas System Sterol Regulatory Elements
CA1320461C (en) * 1988-02-04 1993-07-20 Tatsuya Takano Monoclonal antibody capable of recognizing human arteriosclerosis and process for preparing same
EP0358977A1 (en) * 1988-08-23 1990-03-21 The General Hospital Corporation Cloned nephritis antigen
US5208144A (en) * 1988-08-23 1993-05-04 The General Hospital Corporation Method for detection of human dna containing the gene encoding low density lipoprotein receptor
US5183738A (en) * 1988-09-29 1993-02-02 Japan Immuno Research Laboratories Co., Ltd. Kit for the detection of denatured lipoproteins
US5496926A (en) 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
AU678978B2 (en) * 1992-07-08 1997-06-19 Boehringer Ingelheim International Gmbh Receptor derivates with binding sites for human rhinoviruses
EP0586094A1 (en) * 1992-08-03 1994-03-09 Wisconsin Alumni Research Foundation Soluble LDL receptor and gene
US5756294A (en) * 1995-09-25 1998-05-26 Oncormed, Inc. Susceptibility mutation for breast and ovarian cancer
US6183963B1 (en) * 1998-10-23 2001-02-06 Signalgene Detection of CYP1A1, CYP3A4, CYP2D6 and NAT2 variants by PCR-allele-specific oligonucleotide (ASO) assay
WO2002006467A1 (fr) * 2000-07-18 2002-01-24 Bml, Inc. Methode de detection d'erreurs du metabolisme lipidique
KR100443503B1 (ko) * 2000-12-01 2004-08-09 주식회사디엔에이링크 가족성 고콜레스테롤혈증을 유발하는 인간 저밀도 지단백질 수용체 유전자의 돌연변이체, 이의 검출 방법 및 이 방법에 유용한 프라이머
WO2003076666A1 (en) * 2002-03-08 2003-09-18 Naxcor Compositions and methods for detecting nucleic acid methylation
BRPI0406683A (pt) 2003-01-28 2005-12-20 Lacer Sa Método e dispositivo para a detecção de mutações em sequências de gene isoladas do receptor de lipoproteìna de baixa densidade (ldl-r) que está associada com a hipercolesterolemia familiar
WO2006067254A2 (es) * 2004-12-21 2006-06-29 Lacer, S.A. MÉTODO Y DISPOSITIVO IN VITRO DE DIAGNÓSTICO DE LA HIPERCOLESTEROLEMIA FAMILIAR BASADO EN LA DETECCIÓN DE MUTACIONES EN LA SECUENCIA DEL GEN DEL RECEPTOR DE LIPOPROTEÍNAS DE BAJA DENSIDAD (r-LDL)
US20080109354A1 (en) * 2006-10-04 2008-05-08 Kenneth Baker Account management
CN101565472B (zh) * 2009-05-19 2011-05-04 常州强力电子新材料有限公司 酮肟酯类光引发剂
US9862829B2 (en) 2014-07-23 2018-01-09 Indian Oil Corporation Limited Hybrid modified bitumen composition and process of preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4395486A (en) * 1981-08-19 1983-07-26 Medical College Of Ga. Research Inst., Inc. Method for the direct analysis of sickle cell anemia
IL71505A0 (en) * 1983-04-14 1984-07-31 Hughes Howard Med Inst Phenylalanine hydroxylase cdna clones,their production and their use in the diagnosis of classical phenylketonuria
US4745060A (en) * 1984-12-28 1988-05-17 Board Of Regents, The University Of Texas System Methods and compositions for the detection of Familial Hypercholesterolemia

Also Published As

Publication number Publication date
NL8520436A (nl) 1986-11-03
DE3590702T1 (fi) 1987-07-16
NO863438L (no) 1986-08-27
DK409286A (da) 1986-08-28
DK409286D0 (da) 1986-08-28
GB2178743A (en) 1987-02-18
GB2178743B (en) 1989-08-02
HUT41838A (en) 1987-05-28
FI863474A0 (fi) 1986-08-27
BR8507148A (pt) 1987-03-31
EP0205574A1 (en) 1986-12-30
AU5306586A (en) 1986-07-29
US4745060A (en) 1988-05-17
SE8603591D0 (sv) 1986-08-26
US4966837A (en) 1990-10-30
NO863438D0 (no) 1986-08-27
GB8620715D0 (en) 1986-10-08
WO1986004090A1 (en) 1986-07-17
JPS62501327A (ja) 1987-06-04
CH671776A5 (fi) 1989-09-29
FI863474A (fi) 1986-08-27

Similar Documents

Publication Publication Date Title
SE8603591L (sv) Detektering av erftlig hyperkolesterolemi
Goodenow et al. Identification of a BALB/c H-2Ld gene by DNA-mediated gene transfer
Sasaki et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas
NO165269C (no) Fremgangsmaate ved paavisning av et genetisk materiale.
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DK2289D0 (da) Monoklonale antistoffer samt deres fremstilling og anvendelse
DK265685A (da) Thrombininhibitorer samt deres fremstilling og anvendelse
EP0625212A4 (en) METHODS OF DETECTING ALZHEIMER'S DISEASE.
DK0746332T4 (da) DNA, som koder for et humant neuropeptid Y/peptid YY/pankreas-polypeptidreceptor (Y4), samt anvendelser deraf
ATE92523T1 (de) Verfahren zur abtrennung und reinigung von sialyl-transferasen.
DE60030145D1 (de) Nachweisverfahren für kurze sequenzvarianten
Kuwana et al. Autoantigenic epitopes on DNA topoisomerase I
Lange Evaluation of the simultaneous estimation of anti-dsDNA and anti-ssDNA antibodies for clinical purposes.
GR3030876T3 (en) VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE
ATE122148T1 (de) Menschliche gamma, delta-t-zellen-antigen- rezeptor-polypeptide und nukleinsäuren.
ES8607024A1 (es) Anticuerpos monoclonales
MX9702789A (es) Novedosas proteinas ligandos del dominio de la muerte del receptor tnf, e inhibidores de la union delos ligandos.
US6013461A (en) APC mutation associated with familial colorectal cancer in Ashkenazi Jews
AP2000001917A0 (en) Gene encoding labyrinthin, a marker for cancer.
GR3015284T3 (en) Human macrophage inflammatory protein 2-beta.
WO1999061614A3 (en) Human socs proteins
NO953560D0 (no) Genetiske suppressorelementer assosiert med sensitivitet overfor kjemoterapeutiske medikamenter
JuretiĆ et al. Detection of CML determinants associated with H–2 controlled E β and E α chains
GB2335984A (en) Genetic test for equine severe combined immunodeficiency disease
Kaul et al. Identification of Proliferatively Active Cells by Monoclonal Antibodies Against Dna-Cytosine-5 Methyltransferase

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8603591-2

Effective date: 19871218

Format of ref document f/p: F